UCLA Launches Clinical Study to Test ID-Cap® System’s Technology Impact on HIV Care
UCLA and The Lundquist Institute at Harbor-UCLA Medical Center, led by two Principal Investigators, Dr. Honghu Liu and Dr. Eric Daar, have launched a NIH-funded clinical study to improve HIV treatment outcomes using an innovative integrated intervention that combines ID-Cap® ingestible sensor (IS) digital pill technology measuring adherence to antiretroviral (ARV) medication and IS triggered actions to address challenges to adherence associated with social determinants of health and other factors. The ID-Cap System, developed by etectRx and an FDA-cleared IS, transmits real-time alerts to confirm medication intake, enabling the detection of non-adherence and informing the clinic team in real-time to work with the patient to overcome obstacles to ARV adherence.
Approximately 110 participants will be randomly assigned to either continue standard HIV care or receive the innovative integrated intervention. The ID-Cap System includes a gelatin capsule, embedded with an ID-Cap sensor and encapsulated with various ARV medications, a wearable reader device (choice of wristband or pendant), and a smartphone app (ID-Cap App) that tracks ingestions and sends reminders for missed or late doses.
If no ingestion is detected for three out of five consecutive days via viewing the ID-Cap Dashboard, the Harbor-UCLA HIV Clinic care team will intervene, enabling quick outreach and personalized support. By enhancing real-time communication and enabling earlier intervention, the ID-Cap System may help reduce barriers to care, improve medication management, and contribute to decreased viral loads and, as a result, HIV transmission. Participants also undergo regular viral load testing and complete surveys about their health, behaviors, and access to resources.
This research reflects growing momentum in digital health innovation and holds promise for advancing how HIV care is delivered—bringing smarter, data-driven solutions to the communities that need them most.
###
About etectRx:
etectRx is a leading digital health sensor platform company offering a unique combination of wireless sensor technology, intelligent software, and services through our novel eBurst technology. This technology supports remote monitoring of multiple health conditions, enhancing patient engagement and healthcare outcomes across stakeholders, including patients, providers, and payers, by promoting accountability and awareness.